Thank you, Mr. Chair.
I'd like to thank our guests for being here today.
Drug safety is obviously an important issue for Canadians. When I think about drug safety, one aspect in particular concerns me, and that's the Sandoz matter. Sandoz is a company in Boucherville, Quebec, near my riding. This matter was raised by the mayors of the municipalities in my constituency when I had the opportunity to meet with them recently. After speaking with them and with the people of the region, I am very concerned with this matter.
I use that example because, both in the Auditor General's report and in your statements, you are asking for better language on the labels. But I have a lot of difficulty with that because, for example, a hospital in Toronto found drugs that have been improperly labelled. I have difficulty understanding that we can think about the language on labels when the drugs are not properly labelled to begin with.
What do you think about that? Is that among the improvements that you are going to undertake in applying the Auditor General's recommendations?